Data on the highly diverse plasma response to a drink containing nutrients

Bioavailability of nutrients is highly diverse and depends on a variety of endogenous and exogenous factors in humans. This data article reports on the plasma response of 10 human subjects (5 females, 5 males) to a single dose of a multivitamin drink within 6h (blood taken after 1, 2, 4, and 6h). Nutrients, which were considered in the assessment, were folate (Radioimmuno Assay), vitamin B12 (Radioimmuno Assay) and resveratrol and its plasma metabolites resveratrol-3-O-glucuronide (R3G), resveratrol-4′-O-glucuronide (R4G), resveratrol-3-O-sulfate (R3S) and resveratrol-3-O-4′-O-disulfate (RD, all HPLC). Biological outcome measures were malondialdehyde (MDA, HPLC) and Ferric Reducing ability potential (FRAP, Microplate reader). Mean plasma concentration increased over time significantly for folate (p < 0.05, maximum concentration (Tmax) after 2h), R3G, R4G, R3S (all p < 0.05, Tmax after 1h), RD (p < 0.05, Tmax after 2h) as well as MDA, which decreased (p < 0.05, Tmax after 2h). No significant change was observed for vitamin B12 and FRAP. Within this mean development, individual changes of participants were highly diverse such as for folate from +42 to +422%, for MDA from −49 to +30% or vitamin B12 from −4 to +33%. For R4G 4 out of 10 subjects showed even no increase in plasma at all. For R4G plasma response ranged from 0 to 36 ng/ml, for R3G from 0 to 53 ng/ml or for R4S from 62 to 265 ng/ml. There was no gender difference regarding the plasma response.


a b s t r a c t
Bioavailability of nutrients is highly diverse and depends on a variety of endogenous and exogenous factors in humans. This data article reports on the plasma response of 10 human subjects (5 females, 5 males) to a single dose of a multivitamin drink within 6h (blood taken after 1, 2, 4, and 6h). Nutrients, which were considered in the assessment, were folate (Radioimmuno Assay), vitamin B12 (Radioimmuno Assay) and resveratrol and its plasma metabolites resveratrol-3-O-glucuronide (R3G), resveratrol-4 0 -Oglucuronide (R4G), resveratrol-3-O-sulfate (R3S) and resveratrol-3-O-4 0 -O-disulfate (RD, all HPLC). Biological outcome measures were malondialdehyde (MDA, HPLC) and Ferric Reducing ability potential (FRAP, Microplate reader). Mean plasma concentration increased over time significantly for folate (p < 0.05, maximum concentration (Tmax) after 2h), R3G, R4G, R3S (all p < 0.05, Tmax after 1h), RD (p < 0.05, Tmax after 2h) as well as MDA, which decreased (p < 0.05, Tmax after 2h). No significant change was observed for vitamin B12 and FRAP. Within this mean development, individual changes of participants were highly diverse such as for folate from þ42 to þ422%, for MDA from À49 to þ30% or vitamin B12 from À4 to þ33%. For R4G 4 out of 10 subjects showed even no increase in plasma at all. For R4G plasma response ranged from 0 to 36 ng/ml, for R3G from 0 to 53 ng/ml or for R4S from 62 to 265 ng/ml. There was no gender difference regarding the plasma response.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).

Data description
The present data focuses on the average and individual plasma bioavailability of human adult males and females after the intake of a single dose of a multivitamin drink. Bioavailability of small and medium molecules can vary widely in humans [1e3], which in further consequence lead to heterogeneous biological biomarker outcome measures [4].
A single dose of a multivitamin drink was consumed from healthy male and female adults and defined biomarker, which were part of the drink, measured in the blood of the participants at baseline and periodically up to 6h after intake. Raw and graph Parameters for data collection Human intervention, plasma response to a single dose Description of data collection A concentrated multivitamin beverage (33 ml equivalent to a recommended daily dose) was given to 10 subjects and blood was taken as baseline after 1, 2, 4, and 6h. Folate, vitamin B12 and resveratrol and its plasma metabolites All raw data are given along with the article as supplementary file.

Value of the Data
The data of this article are useful for all readers interesting in the plasma response to a single dose or bioavailability of nutrients and related biological outcomes. Plasma responses based on a single dose administration and the specific focus on the large plasma variation is interesting for researcher in health care, health education, clinical medicine but also food sciences. Biological effects after a single dose administration or a short intervention of a supplement/food are sometimes not significant, which is often due to diverse individual plasma responses of the active compounds, responsible for biological effects such as vitamins or active plant compounds. Therefore, it is important to focus on the concept of hypo-and hyperresponder in every related study, in order to better understand the potential of a supplement/food for improved biological functions or health effects.

Design and blood sampling
Presented data are coming from a single administration dose response after the intake of 33 ml (equivalent to a recommended daily dose) of a multivitamin beverage (vabo-n essentials ©), which consisted of micronutrients and active plant compounds, among them folate, vitamin B12 and resveratrol. 10 healthy adult volunteers (5 males, 5 females, mean age 29.6 ± 7.5 (21e45) years, mean weight 77,1 ± 22,0 (55e121) kg, mean height 174 ± 12 (158e194) cm), were recruited according to defined inclusion and exclusion criteria. In the morning the drink was administered to the subjects (after a 12h overnight fast) and blood was taken at baseline and after 1, 2, 4 and 6 hours with repeated venepunctures. The baseline plasma levels were for MDA 0,60 ± 0,13 mg/l, for folic acid 3,12 ± 1,3 mg/l, for vitamin B12 303 ± 104 ng/l and for FRAP 500 ± 111 mM TEAC. Resveratrol metabolites were not detectable at baseline.
Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki. The protocol was approved by the ethics committee of the University of Vienna (No. 00204).
Plasma/Serum was separated after centrifugation (10 min, 3.000 rpm) immediately after every blood sampling and stored at À80 C until analysis.

Inclusion and exclusion criteria
Inclusion: males & females aged: 20e70 years, healthy and without chronic diseases, capable of signing the informed consent, no intake of vitamin and nutritional supplements 4 weeks prior study entry and over the whole study period; constant nutritional and physical activity habits 4 weeks prior study entry and over the whole study period. Exclusion: males & females younger than 20 years and older than 71 years of age, acute diseases, chronic diseases (cardiovascular, pulmonary and metabolic diseases), pregnant and lactating women, morbid obesity (BMI>40), participation in an other study 30 days prior to study entry, people with organ transplants, subjects with gastrointestinal malabsorption, HIV positive, substance abuse (e.g. alcohol >80 g/d) within the last 2 years, intake of vitamin and nutritional supplements 4 weeks prior study entry and over the whole study period.

Analysis of the ferric reducing ability potential (FRAP)
The antioxidant capacity of serum was measured by performing the ferric reducing ability potential (FRAP) assay as described by Benzie and Strain [6] in triplicates using trolox as standard. Absorbance was measured with at 593 nm and data are expressed as trolox equivalents in mM TEAC.

Analysis of folic acid and vitamin B12
Plasma concentrations of vitamin B12 and folate in plasma were measured by using radioimmunoassay. Standard curves were drawn and sample values calculated according to the protocol published by the kit producer (MP Biomedicals, Germany).

Analysis of resveratrol metabolites
Resveratrol and its glucuronidated and sulfated biotransformation products were quantified by HPLC as described previously [7] using a Dionex UltiMate 3000 HPLC system equipped with an L-7250 injector, an L-7100 pump, an L-7300 column oven (set at 15 C), a D-7000 interface and an L-7400 UV detector (Thermo Fisher Scientific, Waltham, Massachusetts) set at a wavelength of 307 nm. Separation was done on a Hypersil BDS-C18 column (5 mm, 250 Â 4.6 mm I.D., Thermo Fisher Scientific, Inc., Waltham, MA), preceded by a Hypersil BDS-C18 guard column (5 mm, 10 Â 4.6 mm I.D.) at a column temperature of 15 C using a mobile phase consisting of a continuous gradient mixed from 5 mM ammonium acetate/acetic acid buffer, pH 7.4, and methanol at a flow rate of 1 ml/min. Calibration of the chromatogram was accomplished using the external standard method. Linear calibration curves were performed by spiking drug-free cell culture medium with standard solutions of resveratrol, resveratrol-3-O-sulfate, resveratrol-3-O-4 0 -O-disulfate, resveratrol-3-O-glucuronide and resveratrol-4 0 -O-glucuronide to give a concentration range from 0.001 to 10 mg/ml (average correlation coefficients: >0.999). For this method the lower limit of quantification for resveratrol and resveratrol conjugates was 5 ng and 7 ng, respectively. Coefficients of accuracy and precision for these compounds were <11%.
The outcome of all parameters are shown in Fig. 1. Raw data are shared as supplementary file.

Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics 23. To assess the overall differences between the time points, the Friedman test was conducted and if significant, the Wilcoxon test was used to calculate the differences between each time point by considering Bonferroni correction. The data are expressed as mean ± SEM (MIN e MAX). P < 0.05 was considered as statistically significant.

Funding
This work was supported by the University of Vienna and Vabo-N. None of the funders has a financial interest.